Skip to main content

Arbutus Biopharma Corporation (ABUS)

NASDAQ: ABUS · IEX Real-Time Price · USD
2.50
-0.04 (-1.57%)
At close: Dec 29, 2023, 4:00 PM
2.48
-0.02 (-0.80%)
After-hours: Dec 29, 2023, 7:58 PM EST

Arbutus Biopharma Revenue

Arbutus Biopharma had revenue of $22.24M in the twelve months ending September 30, 2023, down -38.19% year-over-year. Revenue in the quarter ending September 30, 2023 was $4.66M, a -21.74% decrease year-over-year. In the year 2022, Arbutus Biopharma had annual revenue of $39.02M with 255.11% growth.

Revenue (ttm)
$22.24M
Revenue Growth
-38.19%
P/S Ratio
18.85
Revenue / Employee
$231,677
Employees
96
Market Cap
419.24M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202239.02M28.03M
255.11%
Dec 31, 202110.99M4.07M
58.92%
Dec 31, 20206.91M903.00K
15.02%
Dec 31, 20196.01M66.00K
1.11%
Dec 31, 20185.95M-4.76M
-44.44%
Dec 31, 201710.70M9.21M
617.64%
Dec 31, 20161.49M-21.79M
-93.59%
Dec 31, 201523.28M8.32M
55.66%
Dec 31, 201414.95M-512.00K
-3.31%
Dec 31, 201315.47M1.36M
9.64%
Dec 31, 201214.11M-2.71M
-16.10%
Dec 31, 201116.81M-4.54M
-21.27%
Dec 31, 201021.35M6.93M
48.00%
Dec 31, 200914.43M2.70M
22.99%
Dec 31, 200811.73M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
The Pennant Group 523.60M
Bioventus 502.76M
Canopy Growth 261.66M
AirSculpt Technologies 189.01M
Avid Bioservices 140.94M
Talkspace 137.87M
Fulcrum Therapeutics 2.62M
Cibus 756.00K
Revenue Rankings

ABUS News

More News